Vanguard Group
NXL icon

Vanguard Group’s Nexalin Technology NXL Stock Holding History

Vanguard Group’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$99.3K Buy
5,931
+45
+0.8% +$1.52K ﹤0.01% 4179
2025
Q3 		$162K Buy
5,886
+557
+10% +$15.8K ﹤0.01% 4158
2025
Q2 		$163K Hold
5,329
– – ﹤0.01% 4105
2025
Q1 		$312K Buy
5,329
+1,147
+27% +$94K ﹤0.01% 3988
2024
Q4 		$346K Buy
4,182
+3,123
+295% +$261K ﹤0.01% 4024
2024
Q3 		$21.3K Hold
1,059
– – ﹤0.01% 4299
2024
Q2 		$53.7K Buy
+1,059
New +$46.7K ﹤0.01% 4286

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Group's NXL Position: Q4 2025 in Review

Vanguard Group increased its Nexalin Technology (NXL) stake by 0.76% in Q4 2025, buying an estimated $1.52K and bringing the position to 5,931 shares worth $99.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

Vanguard Group first reported a position in NXL in Q2 2024 and has held it in 7 quarters since. The position peaked at $346K in Q4 2024. 19 funds tracked by Wall St. Rank hold NXL as of Q4 2025.

  • Vanguard Group held 5,931 shares of Nexalin Technology worth $99.3K as of Q4 2025.
  • Vanguard Group bought 45 Nexalin Technology shares in Q4 2025, an estimated $1.52K.
  • Nexalin Technology made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4179 holding.
  • Vanguard Group first reported a position in Nexalin Technology in Q2 2024 and has held it in 7 quarters since.
  • Vanguard Group's Nexalin Technology position peaked at $346K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held Nexalin Technology as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.